QP Medtech Chris

Carl Christopher Tornblom

Chairman of the board


Chris is founder and investor in several growth companies and has vast experience of the financial markets in a number of countries. He is currently the CEO of Metacon AB, an international energy technology company listed on NGM Nordic MTF in Stockholm.

He has served on the board of a number of listed companies, both in Sweden and abroad. He has lived and worked in, among others, the United States, United Kingdom, Germany, Switzerland and South Africa. He is educated at Shenandoah University in the USA and the Graduate School of Business Administration in Zurich, Switzerland.

QP Medtech Fastbom Johan69

Professor Johan Fastbom

Senior advisor and Product Development


Johan is the founder of Quality Pharma. He gained his degree in medicine at Karolinska Institutet 1984, where in 1988 he also gained his PhD in pharmacology with the thesis “Adenosine receptors in the central nervous system, autoradiographic and functional studies.” During the period 1990-1994 he worked as a physician and then a consultant at the department of clinical pharmacology at Karolinska Hospital.
Between 1992 and 1993 he was a house officer in internal medicine at Karlskoga hospital. In 1994 he became a specialist in clinical pharmacology at Karolinska University Hospital in Solna, and in 1998 an associate professor of geriatric pharmacology at Karolinska Institutet. From 1994 to 2002 he was employed as a senior research fellow at the then Neurotec department, and from 2002 to 2011 as a senior lecturer at the Karolinska Institutet’s Aging Research Center (ARC), a position which still occupies most of his working hours.
Since 2000 he has also had a 40 per cent project employee position at the National Board of Health and Welfare investigating pharmaceutical questions, and since 2002 he has been a consultant at the geriatric clinic at Karolinska University Hospital in Huddinge.
Johan Fastbom was appointed professor of geriatric pharmacology at Karolinska Institutet in 2011.

Josep Lluís Falcó

Senior Advisor


Josep Lluís is the founder and CEO of Genesis Biomed. He has 20 years of experience in the biomedical sector. He has worked for big pharma companies (Sanofi), mid-size pharmas (Ferrer Grupo), small biotechs (Hospital spin-off), Tech Transfer Offices (Fundació Bosch i Gimpera) and consulting firms (Antares Consulting and Asphalion). He has also been associate professor at IQS.
His experience is based in Healthcare Strategy, Technology Transfer, Fundraising of start-up companies, Business Development, Marketing, Market Access, Reimbursement and Regulatory Affairs.
Josep Lluís has founded 4 companies. He currently serves as board member for 3 start-up companies and he is mentor of several entrepreneurs. In addition in the last 4 years he has been involved in 6 private fundraising processes and he has contributed to raise 33,5 million euros for his clients.
The projects in which Josep Lluís has been involved are based in small chemical entities, biologicals, diverse medical devices, in vitro diagnostics, nutraceuticals and cosmetics. The therapeutic areas where he has recently worked are Oncology, Central Nervous System, Cardiovascular, Ophthalmology, Orthopedics, Traumatology, HIV, Microbiome, Antibacterials and Immunomodulation. He has global knowledge of drug/device development, having worked in Discovery, Preclinical and Clinical phases, Marketing and Post-Marketing.
Doctor in Chemistry (Institut Químic de Sarrià, 2001) and MBA (UB, 2007)